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Abstract 
Hypusine modification of eukaryotic initiation factor 5A (eIF-5A) represents a unique and highly 
specific posttranslational modification with regulatory functions in cancer, diabetes and 
infectious diseases. However, the specific cellular pathways that are influenced by the hypusine 
modification remain largely unknown. To globally characterize eIF-5A and hypusine-dependent 
pathways, we used an approach that combines large-scale bioreactor cell culture with tandem 
affinity purification and mass spectrometry: ‘bioreactor-TAP-MS/MS’. By applying this 
approach systematically to all four components of the hypusine modification system (eIF-5A1, 
eIF-5A2, DHS and DOHH), we identified 248 interacting proteins as components of the cellular 
hypusine network, with diverse functions including regulation of translation, mRNA processing, 
DNA replication and cell cycle regulation. Network analysis of this dataset enabled us to provide 
a comprehensive overview of the protein-protein interaction landscape of the hypusine 
modification system. In addition, we validated the interaction of eIF-5A with some of the newly 
identified associated proteins in more detail. Our analysis has revealed numerous novel 
interactions, and thus provides a valuable resource for understanding how this crucial 
homeostatic signaling pathway affects different cellular functions. 
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Introduction 
Cellular homeostasis is controlled by signaling networks that communicate through 
posttranslational modifications (PTM) of proteins, including phosphorylation, acetylation and 
methylation (1-3). These modifications are typically attached to various types of proteins by 
multiple independent enzymes, and thereby simultaneously regulate a wide range of protein 
functions. Consequently, most signaling pathways are highly redundant, enabling maintenance of 
cellular integrity even if the modification of a single signaling molecule is disrupted (4). A 
striking exception is hypusine. This essential PTM is limited to a single protein: the eukaryotic 
initiation factor 5A (eIF-5A) (5). Disruption of this PTM leads to growth arrest in proliferating 
eukaryotic cells and is fatal for the developing mammalian embryo (6, 7). During hypusine 
biosynthesis, the lysine residue at position 50 (Lys50) in eIF-5A is converted into the unusual 
amino acid hypusine (N
ε
-(4-amino-2-hydroxybutyl)lysine; depicted in Fig. 1A) (5). This process 
activates eIF-5A and is mediated by two enzymatic reactions: first, deoxyhypusine synthase 
(DHS) catalyzes the transfer of the 4-aminobutyl moiety of spermidine to the ε-amino group of 
Lys50 to form an intermediate residue, deoxyhypusine (Dhp50) (8). Subsequently, deoxyhypusine 
hydroxylase (DOHH) mediates the formation of hypusine (Hyp50) by addition of a hydroxyl 
group to the deoxyhypusine residue (9). eIF-5A, DHS and DOHH are all essential for 
proliferation of higher eukaryotic cells (10, 11), and eIF-5A is strictly conserved throughout 
eukaryotic evolution (12). 
The eIF-5A protein has been proposed to promote various different cellular processes that 
potentially regulate proliferation, including translation initiation (13) and elongation (14) as well 
as nucleocytoplasmic transport of RNA or other cargoes (15, 16). Using inhibitors of DHS and 
DOHH or eIF-5A mutants deficient for hypusine modification, it has also been shown that this 
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modification is a prerequisite of at least a subset of known eIF-5A functions (10, 11, 17, 18). The 
eIF-5A protein has also been implicated in numerous pathologic conditions including various 
types of cancer (19-23), β-cell inflammation (and therefore diabetes) (24) and HIV-1 infection 
(25). Human and rodent cells carry two highly homologous eIF-5A genes coding for distinct 
isoforms. While eIF-5A1 is expressed at high levels throughout all tissues, eIF-5A2 is detectable 
only in a few embryonic tissues as well as adult testis, central nervous system (26) and cancer 
tissue (21, 22, 27-29). 
Although there have been ample reports suggesting eIF-5A is involved in translational control, 
the molecular mechanisms through which it ultimately influences cellular physiology and leads to 
disease remain unclear. Moreover, it remains equally possible that at least some of eIF-5A’s 
effects on cellular functions might not involve direct effects on translation. Also, there is no 
information available on whether the two isoforms of mammalian eIF-5A are functionally 
congruent.  
To address these fundamental questions systematically and comprehensively, we employed a 
bioreactor-based tandem affinity purification (TAP) approach followed by mass spectrometric 
(MS) identification of purified protein complexes (‘bioreactor-TAP-MS/MS’). In order to obtain 
a complete interaction map of the proteins involved in hypusine modification, we used this 
approach to identify interaction partners of both isoforms of eIF-5A, as well as the hypusine 
modification enzymes DHS and DOHH. In total, we identified 248 proteins that either directly 
interact with these bait proteins or are components of higher complexes containing the 
aforementioned proteins. Furthermore, we validated a subset of putative interaction partners of 
both eIF-5A isoforms, using Western blots of reciprocal TAP experiments, as well as a live-cell 
protein-fragment complementation assay (PCA). Our analysis provides a molecular framework 
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for a detailed understanding on how this signal transduction pathway affects different crucial 
cellular functions. 
Experimental procedures 
Cloning of plasmid constructs 
A retroviral pCeMM expression plasmid encoding a C-terminal SG-tag was kindly provided by 
Prof. Superti-Furga, Vienna, A, (30); pcDNA3 expression plasmids containing the MCFD2 
insert, C-terminally fused to YFP1 and YFP2 fragments, were kindly provided by Prof. H.-P. 
Hauri, Basel, CH (31); and an expression plasmid encoding LC3 protein N-terminally fused to 
monomeric red fluorescent protein (mRFP-LC3) (32, 33) was obtained from Addgene, 
Cambridge, MA. To generate more versatile cloning vectors for the protein fragment 
complementation assay (PCA), the tag sequences were PCR-amplified from the plasmid DNA 
and cloned into empty pcDNA3 plasmid as described above, thereby including a new multiple 
cloning site. The LC3 sequence of mRFP-LC3 was exchanged for cDNA sequences of 
calreticulin (NM_007591), Dcp1a (NM_133761), TIA-1 (NM_011585) and TSG101 
(NM_021884). The N-terminal mRFP tag sequences were subsequently removed and the 
sequence coding for Cerulian 2 (Cer2) inserted into the plasmid (a LeGO plasmid encoding Cer2 
was a kind gift of Prof. B. Fehse, Hamburg, D). All plasmids were built using standard RT-PCR- 
and restriction-enzyme based cloning. The TAP- and PCA-constructs used in this study are 
provided in Table S5. Point mutants coding for all eIF-5AK50R and G52A mutants were generated 
using the Phusion site directed mutagenesis kit (Finnzymes, Vantaa, FIN). 
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Cell culture 
NIH3T3 were cultivated in Dulbecco’s modified Eagle’s medium (DMEM) + GlutMAX-I 
supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml 
streptomycin. Vero cells (ATCC-CCL81, kidney epithelial cells from Cercopithecus aethiops) 
were cultivated in DMEM supplemented with 10% FBS. Ba/F3 cells expressing oncogenic Bcr-
ABL (Ba/F3 p210; kindly provided by Prof. C. L. Sawyers, Los Angeles) were cultivated in 
RPMI 1640 + GlutaMAX-I supplemented with 10% FBS, 1 mM sodium pyruvate, 1x MEM non-
essential amino acids, 100 U/ml penicillin and 100 µg/ml streptomycin. All Media and 
supplements from Gibco (Life Technologies, Darmstadt, D). All cells were incubated at 37°C, 
5% CO2 and 95% relative humidity. 
Bioreactor-based tandem affinity purification (bioreactor-TAP) 
In order to establish stable bait expressing cell lines, separate retroviral transductions of the 
Ba/F3 p210 cell line were performed with each pCeMM construct. Retroviral transduction was 
carried out as described before (23, 34). In order to ensure constant cell culture conditions, we 
decided to employ bioreactor based cell cultivation rather than flask-based cell culture. This 
approach enabled us to generate high numbers of cells and maintain constant and reproducible 
culture conditions (35). Due to the high reproducibility of separate reactor runs, we decided to 
split samples of reactor-cultured cells after lysis, thus providing technical replicates of the more 
error-prone downstream processes. This approach was applied to the following bait proteins: eIF-
5A1, eIF-5A2, DHS, DOHH and eGFP (providing the bead proteome control dataset). The TAP 
procedure was adapted from Bürckstümmer et al. (30). In short, up to 10
10
 cells expressing one of 
the bait proteins were washed in PBS and lysed 15 min in 50 mM Tris at pH 7.6 containing 
125 mM NaCl, 5% glycerol, 0.2% NP-40, 1.5 mM MgCl2, 25 mM NaF, 1 mM Na3VO4 and 1x 
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protease inhibitor cocktail (Sigma, St. Louis, MO). The lysate was cleared (48,000 g, 45 min). 
Supernatants of scale-up experiments for mass spectrometric identification were now split into 
two separately handled fractions. The supernatant was incubated with IgG-beads (GE Healthcare, 
Uppsala, SE) for 2 h, and the beads washed three times with lysis buffer and three times with 
TEV reaction buffer (10 mM Tris at pH 7.6, 100 mM NaCl, 0.2% NP-40 and 0.5 mM EDTA). 
The SG-tag was cleaved by incubation with acTEV protease (Invitrogen, Carlsbad, CA) for 3 h, 
directly followed by incubation of the supernatant with streptavidin beads (Thermo Scientific, 
Waltham, MA) for 1 h. The beads were washed three times and the bound protein complexes 
eluted by boiling in SDS lysis buffer (50 mM Tris-HCl, pH 7.6 containing 150 mM NaCl, 1% 
NP-40, 0.25% Na-desoxycholate and 1x protease inhibitor cocktail). Eluates for mass 
spectrometry were separated by 1D-PAGE over a length of 2 to 4 cm. Gels were stained using 
RotiBlue (Carl Roth, Karlsruhe, Germany) and sliced into 8 to 10 samples per replicate. 
3
H-labeled spermidine incorporation assay 
Incorporation of 
3
H-labeled spermidine into the hypusine modification of eIF-5A was quantified 
as described in detail by Wolff et al. (36, 37). 
Mass spectrometry 
Proteins were digested in-gel using 10 ng/µl trypsin in 20 mM ammonium bicarbonate and 
incubated at 37°C overnight, followed by peptide extraction with 50% acetonitrile containing 
0.1% acetic acid. The supernatants were dried and peptides were dissolved in 10 µl buffer 
containing 0.1% acetic acid and 2% acetonitrile. The peptide solutions were analyzed either using 
a FTICR mass spectrometer (Finnigan LTQ FT, Thermo Electron Corp., D) coupled to a 
nanoACQUITY Ultra Performance LC (UPLC) (Waters Corp., USA) and controlled by Xcalibur 
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software (Thermo Electron Corp., D) or using a Proxeon Easy nLC (Proxeon Biosystems A/S, 
Denmark) connected to a LTQ-Orbitrap XL (Thermo Electron Corp., D) and equipped with a 
nano-ESI source. 
In detail, the peptides for FTICR measurements were enriched on a nanoACQUITY Symmetry 
C18 pre-column (2 cm length, 180 µm inner diameter and 5 µm particle size, Waters Corp.) and 
separated using NanoAcquity BEH130 C18 column (10 cm length, 100 µM inner diameter and 
1.7 µm particle size, Waters Corp.) on a nanoACQUITY UPLC. The separation was achieved 
with the formation of a linear gradient of 92 minutes containing buffer A (2% acetonitrile in 
water with 0.1% acetic acid) and buffer B (acetonitrile with 0.1% acetic acid, gradient-1-5% 
buffer B in 2 min, 5-25% B in 63 min, 25-60% B in 25 min, 60-99% B in 2 min). The peptides 
were eluted at a flow rate of 400 nl/min and analyzed using FTICR mass spectrometer with a 
nano-ESI source. The full scan was carried out using FTMS analyzer with normal mass range of 
m/z 400-1500. The data was acquired in profile mode with a resolution of 50,000 and positive 
polarity. This was followed by data dependent acquisition of top five intense precursor ions for 
MS/MS scans using CID activation. A minimum of 1,000 counts were activated for 30 ms with 
an activation of q = 0.25 and a normalized collision energy of 35%. The charge state screening 
and monoisotopic precursor selection was enabled with the rejection of +1 and unassigned charge 
states. The peptides were excluded for the next 60 s once they were subjected to MS/MS scans. 
For the measurements on the LTQ Orbitrap XL mass spectrometer, the peptides were separated 
using Proxeon Easy nLC and an Acclaim PepMap 100 analytical column (C18, particle size 
3 μm, bed length 15 cm, 100 Å, LC-Packings, Dionex, USA). The peptides were enriched on a 
Biosphere C18 pre-column (ID 100 µM, particle size 5 µm, lenght 20 mm, pore size 120 Å, 
NanoSeparations, NL). The peptides were eluted at a flow rate of 300 nl/min with formation a 
Protein-Protein-Interaction Network Organization of the Hypusine Modification System 
 
 9 
solvent gradient of Buffer A and B (1-2% buffer B in 1 min, 2-25% B in 59 min, 25-40% B in 
10 min, 40-100% B in 5 min). The buffer composition of A and B were same as used for UPLC. 
The MS was operated in data-dependent mode to automatically switch between Orbitrap-MS and 
LTQ-MS/MS acquisition. Survey full scan MS spectra (from m/z 400 to 1500) were acquired in 
the Orbitrap with resolution R = 60,000. The method used allowed sequential isolation of up to 
five of the most intense ions, depending on signal intensity and for fragmentation on the linear 
ion trap using collision-induced dissociation. Target ions already selected for MS/MS were 
dynamically excluded for 60 s. General MS conditions were 1.6 kV electrospray voltage with no 
sheath and auxiliary gas flow. Ion selection threshold was 1,000 counts for MS/MS; an activation 
Q-value of 0.25 and activation time of 30 ms were also applied for MS/MS. 
Protein identification was performed by automated database searches using the Sequest algorithm 
rel. 27.11 (Sorcerer built 4.04, Sage-N Research Inc., Milpitas, CA) and the Swiss-Prot database 
rel. 57.15 (forward-reverse, limited to 32448 mouse entries). The considered enzyme specificity 
was fully tryptic allowing 2 missed cleavages. Parent and fragment mass tolerance (MS) were set 
to 10 ppm and 1 Da, respectively. Methionine oxidation and carbamidomethylation (on C) were 
considered as optional modification. Protein identification was based on a) peptide thresholds, 
with a 95.0% confidence minimum, Sequest: ΔCn scores of greater than 0.4, and XCorr scores of 
greater than 2.0 or 3.5 for doubly and triply charged peptides, respectively; and b) protein 
thresholds, with 95.0% confidence and 2 peptides identification minima. 
Bioinformatic evaluation of identified PPI for the HMS 
The resulting identifications for each bait protein were filtered for proteins that were identified in 
both technical replicates. Hits flagged as bead proteome were also removed from each dataset. 
The adjusted lists were combined into one spoke interaction map using Cytoscape 2.8.1 (38). 
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Furthermore, the network was enriched by using IPA 9.0 (Ingenuity Systems, Redwood City, 
CA) and Uniprot (39) to annotate function and subcellular localization for the prey proteins. The 
datasets were uploaded to STRING 9.0 (40) and IntAct 3.1 (41) databases to interconnect 
network nodes by adding previously reported interactions. The ClusterONE Cytoscape plugin 
0.92 (42) was used to identify significantly interconnected clusters of nodes in the final 
interaction map. The PANTHER database 7.0 (43, 44) was used for gene ontology analysis, 
while bacterial/yeast/mammalian orthologs of proteins were queried from the OMA browser (45). 
Western blotting 
All Western blot analysis was performed as described previously (46, 47). The employed 
antibodies were rabbit anti-eIF-5A1 (Novus Biologicals, Littleton, CA), rabbit anti-Myc-tag (Cell 
Signaling, Boston, MA), and anti-rabbit-HRP (Cell Signaling). 
Protein Fragment Complementation Assay (PCA) 
3T3 cells were seeded the day before transfection at a density of 10
5
 cells per well in 24-well 
format and transfected using Lipofectamin 2000 (Invitrogen, Carlsbad, CA) according to 
manufacturer’s instructions, with a total of 3 μg plasmid DNA and 6 µl transfection reagent per 
well. Fluorescence-microscopic and flow cytometric analyses were carried out 24 h after 
transfection, recording mean fluorescence values of whole viable cell populations. Fluorescence 
microscopy was carried out using an IX81 fluorescence microscope equipped with a U-RFL-T 
high pressure mercury burner (Olympus, Tokyo, JP). Quantitative analysis was carried out using 
a FACSCalibur flow cytometer (BD, Franklin Lakes, NJ). 
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Fluorescence microscopy and immunolabeling of PCA-transfected cells 
Vero cells (ATCC-CCL81, kidney epithelial cells from Cercopithecus aethiops) were seeded 
onto 10 mm cover slips in 24-well plates at 1×10
5
 cells/well and the next day transfected with 
0.5 µg plasmid DNA per well (0.25 µg each of pcDNA3 eIF-5A1-YFP1 and pcDNA3 DHS-
YFP2) using TransIT LT1 (Mirus Bio, Madison, WI). One day after transfection, the cells were 
fixed with 3% PFA in PBS containing calcium and magnesium for 20 min. PFA was quenched by 
washing with 50 mM NH4Cl in PBS and the cells were permeabilised with 0.1% Triton X-100 in 
PBS for 5 min. After blocking with 0.5% BSA in PBS, immunolabeling was performed with anti-
calreticulin or anti-EEA1 (both Abcam, Cambridge, MA). Secondary antibodies were coupled to 
Alexa633 (Life Technologies, Grand Island, NY). The specimens were analyzed on an Axiovert 
200M microscope equipped with an LSM 510 META confocal laser scanning unit (Zeiss, Jena, 
Germany) using a Plan-Apochromatic ×63 oil immersion objective lens with a 1.4 numeric 
aperture. Image acquisition and processing was performed by using the Zeiss LSM imaging 
software and Adobe Photoshop CS3 (Adobe Systems, San Jose, CA). 
Statistical Analysis 
All PCA combinations were carried out in parallel duplicates paired with appropriate controls. 
Runs were independently reproduced to a total n of 4 wells per combination and all values 
analyzed using one-way ANOVA repeated measures test, with Dunnett or Bonferroni post tests 
applied where appropriate, as all combinations were compared with the respective MCFD2 
negative control and/or all other wild type and mutant forms of the same protein. Differences of 
mean fluorescence values normalized to the MCFD2 negative control with P < 0.05 were 
considered statistically relevant. Significances are represented with asterisks (*), with * for 
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P < 0.05, ** for P < 0.01 and *** for P < 0.001. Diagrams of PCA experiments show means of 
fluorescence values (columns) and standard error of the mean (SEM, error bars). 
Results 
Detection of protein-protein interactions of the hypusine modification system using 
bioreactor-TAP-MS/MS 
A schematic overview of the workflow described in this manuscript is presented in Figure S1. 
The HMS proteins were tagged with a streptavidin-IgG-tag (SG) and stably expressed via 
pCeMM (30) expression vectors (Fig. 1B). C-terminal tagging was chosen as N-terminal tags 
impede the hypusine modification of eIF-5A. To investigate the effect of the hypusine 
modification on newly identified PPI, we also constructed two mutant forms of eIF-5A: The Arg-
substitution of Lys50, the residue that is used for hypusine biosynthesis, as well as the substitution 
of Gly52 by Ala. Importantly, both eIF-5AK50R and eIF-5AG52A mutations prevent the biosynthesis 
of hypusine (48). To enable mapping of newly identified PPI to distinct domains of eIF-5A, two 
deletion mutants (eIF-5A1-83 and eIF-5A84-154) were also cloned, representing the functionally and 
structurally distinct N- and C-terminal domains of this protein (49) (Fig. 1B). A 
3
H-spermidine 
incorporation assay (50) demonstrated that both eIF-5A1 (SG) and eIF-5A2 (SG), as well as the 
eIF-5A1-83 (SG) deletion mutants, displayed efficient incorporation of 
3
H-spermidine, as 
compared to the hypusine-modification deficient mutants (Fig. 1C). 
As shown by Western blot, we obtained robust constitutive expression of SG-tagged bait proteins 
eIF-5A1, eIF-5A2, DHS, DOHH, and eGFP at comparable levels (Fig. 1D). Maintenance of 
optimal and standardized conditions during cell expansion is a prerequisite for reliable, 
reproducible, and comparable results; particularly since many PPI are highly dynamic depending 
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on the conditions of both the intra- and extracellular environment. Flask-based cell culture does 
not allow for monitoring and constant adjustment of crucial culture conditions like medium pH or 
glucose concentration. Therefore, the generation of reliable and reproducible PPI networks is 
usually accomplished by analyzing biological replicates from independent flask-based cell 
cultures. To optimize cell culture conditions and reproducibility of downstream processes, we 
utilized a 5 l bioreactor for the rapid production of Ba/F3 p210 suspension cells expressing the 
respective bait protein, rather than flask-based cell culture. The rationale for using Ba/F3 p210 
cells was that we have previously shown eIF-5A to exert a specific effect on chronic myeloid 
leukemia (23), for which this cell line is an established model system. As shown in Figure S2, the 
bioreactor enabled the monitoring and adjustment of medium pH and dissolved oxygen at regular 
intervals. Additionally, yields of up to 10
10
 cells were achieved as starting material for the TAP 
assay without reaching glucose limitation. Taken together, these factors ensured optimal and 
reproducible conditions for cell culture. The monitoring of key parameters also revealed high 
comparability of the different reactor runs. We therefore concluded that preparing technical 
replicates of the TAP-MS/MS workflow from one batch of cells grown under the same conditions 
in the bioreactor, in contrast to producing flask-based biological replicates, would be a valid 
approach with regard to reproducibility. Coomassie staining of bioreactor-TAP outputs separated 
by 1D SDS-PAGE revealed striking differences in the protein band patterns for different bait 
proteins, suggesting that specific interactions were readily detectable using this approach (Fig. 
1E). 
Two complementary control experiments to validate putative novel interaction partners were 
implemented: First, all proteins that co-purified with eGFP (SG) were flagged as bead proteome 
to identify false positive interaction partners (51, 52). Second, cell lysates were split in two equal 
Protein-Protein-Interaction Network Organization of the Hypusine Modification System 
 
 14 
samples and handled separately throughout the whole purification and identification process, so 
that full technical replicates were obtained and enabled the exclusion of residual unspecific 
contaminations in the TAP outputs. 
Construction and evaluation of the PPI network of the proteins involved in the hypusine 
modification system 
After MS/MS analysis, 550 proteins were identified in all analyzed MS/MS samples. By 
application of both the bead proteome and replication filters, we were able to identify 248 
proteins that potentially interact with the four HMS proteins. The filtered lists of proteins 
identified in this study are provided in Table S1, together with the list of proteins flagged as bead 
proteome. Revision of the bead proteome dataset revealed that it contained eIF-5A1 as one of the 
non-specifically purified proteins. As this protein was used as a bait protein, and as its interaction 
to the other bait proteins is well-documented within the literature, we decided to omit removing 
eIF-5A1 from the remaining datasets upon application of the bead proteome filter. As the main 
focus of this study was to identify unknown PPI of the HMS, the inclusion or exclusion of eIF-
5A1 in the dataset was of no practical consequence. 
To annotate the biological relevance of the newly identified PPI, we next analyzed the proteins in 
several ways: first, we constructed an interconnected network from our list of specifically 
interacting proteins as described in ‘experimental procedures’ (Fig. 2A). Nodes with red borders 
represent proteins that were identified previously, but not in this study. These proteins were 
excluded from further analyses. Notably, database searches revealed only 35 known mammalian 
interaction partners, 10 of which were also identified in our TAP outputs (Fig. 2B). Thus, this 
study reports approximately seven times the number of proteins to be involved in the HMS, 
compared to formerly available studies. Between eIF-5A1 and eIF-5A2, a significant overlap of 
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72 proteins exists that represents 33.3% of the eIF-5A1 and 82.8% of the eIF-5A2 dataset. 
Moreover, 138 (55.2% of total) proteins were uniquely detected with eIF-5A1 (Fig. S3). A 
significant number of proteins nevertheless appeared to display isoform-specific interactions, 
supporting the idea of specialized functions for these proteins. 
We next concentrated our analysis on enriched functional clusters contained in the network (Fig. 
3A to E). Cluster analysis of a network can indicate functional modules of protein complexes that 
were co-purified with the bait protein (53), hence we applied cluster analysis to our entire HMS 
network. This approach revealed five significantly interconnected functional clusters, the largest 
one consisting of 18 ribosomal proteins of the large subunit, 3 proteins of the small ribosomal 
subunit, and the translation initiation factors eIF-2α (eIF2s1, Q6ZWX6), eIF3a (P23116) and 
eIF3b (Q8JZQ9), eIF-4B (Q8BGD9), and eIF-5B (Q05D44), totaling 26 proteins with a P-value 
of 1.38×10
-9
 (Fig. 3A). Another cluster included 10 nuclear proteins that are mainly active in 
RNA processing and transport (P = 8.65×10
-5
), namely U2af2 (P26369), SF3b130 (Q921M3), 
ASF/SF2 (Q6PDM2), serine/arginine-rich splicing factor 7 (Q8BL97), hnRNP A2/B1 (O88569), 
-D0 (Q60668), -U (Q8VEK3), and -X (α-CP2, Q61990), Ptbp1 (P17225), and nuclear RNA 
export factor 1 (Q99JX7) (Fig. 3B). Six members of the T-complex chaperonin family (TCP-1-γ 
(P80318), -δ (P80315), -ε (P80316), -η (P80313), and -θ (P42932), as well as Cct6a (P80317)), 
comprised a third cluster (P = 0.002) (Fig. 3C). The three RNA-binding proteins nucleolin, NPM 
(Q61937) and tRNA (cytosine-5)-methyltransferase NSUN2 (Q1HFZ0), as well as 4 proteins 
active in mitosis and cell cycle control (Ckap5 (A2AGT5), RCC2 (Q8BK67), and kinesin-like 
proteins KIF2A (P28740) and KIF2C (Q9QWT9)) are contained in the remaining two clusters 
(P = 0.029 and P = 0.039, respectively) (Fig. 3D and E). 
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We further compared our PPI network with a network built from data of high-throughput 
experiments in yeast, accessible via the IntAct (41) and STRING (40) databases (Fig S4A). Of 
115 interacting proteins that we were able to extract from these databases, we only processed 68 
that we could assign to mammalian orthologs via the OMA browser (45). 26 (38.2%) of these 
proteins’ orthologs were also included in our dataset, 3 of which were removed from our 
interaction network due to appearance in the bead proteome (Fig. S4B). Interaction enrichment of 
the intersecting yeast and mammalian protein sets via STRING and a direct comparison of both 
resulting networks showed that especially the interactions between eIF-5A and the ribosomal 
complex display high evolutionary conservation. 
Gene ontology (GO) analysis reveals highly significant enrichment of interacting proteins 
implicated in translation and RNA metabolism 
To obtain a comprehensive view of the mammalian HMS interactome, we next asked whether 
specific molecular functions or biological processes were enriched in our sets of identified 
proteins (Table S1). The gene ontology (GO) categories that were identified as significantly 
enriched in our datasets using the PANTHER (43, 44) database are shown in Figure S5. In the top 
category ‘biological process’, the most significantly enriched categories were ‘(protein) 
metabolic process’ (which contains ‘translation’), as well as ‘cellular process’ (and therein ‘cell 
cycle’ and ‘cell communication’). The second dominant category in ‘metabolic process’ was 
‘nucleic acid metabolic process’ (itself containing ‘RNA metabolic process’). The GO analysis 
for ‘molecular function’ showed ‘catalytic activity’ and ‘binding’ as most enriched categories. 
Therein, the terms ‘helicase activity’, ‘ligase activity’, ‘transferase activity’, ‘hydrolase activity’ 
and ‘RNA splicing factor activity’, as well as ‘nucleic acid binding’ and ‘protein binding’, 
respectively, were returned as the most enriched subcategories. Collectively, these findings 
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further support the commonly proposed roles for eIF-5A in protein translation, RNA metabolism 
and transport, as well as cell cycle regulation. However, proteins annotated to other ontologies 
are also enriched in the four datasets to various degrees according to the GO report, hinting at 
possible additional unidentified cell biological roles of the HMS. 
Validation of novel interaction partners using a protein fragment complementation assay 
(PCA) 
As an initial validation method, we used a protein fragment complementation assay (PCA) 
employing split-YFP fusion proteins (31) (Fig. 4A). We first tested the applicability of this assay 
to our bait proteins, using the previously reported homodimerization of eIF-5A as well as its 
interaction with both DHS and DOHH as positive control experiments. As shown in Figure 4B 
and C, both DHS- and DOHH-YFP2 fusions elicited significant enhancement of fluorescence 
over background levels in combination with the eIF-5A1-YFP1 fusion. Similar fluorescent 
enhancement was also observed when eIF-5A1-YFP1 was tested with YFP2 fusions of eIF-5A1. 
In contrast, no enhancement over background was observed when MCFD2-YFP1 was tested with 
the respective YFP2 fusions as a negative control. However, MCFD2-YFP1 combined with 
ERGIC-53-YFP2, a known interaction partner of this protein (31), showed a positive signal 
comparable to those of the eIF-5A combinations (Fig. 4B). These effects could also be confirmed 
by fluorescence microscopy (Fig. 4C). Interestingly, the combination of DHS and eIF-5A fusion 
proteins resulted in the occurrence of small speckles of high and only little diffuse fluorescence 
activity (Fig. 4C, right panel). We concluded that this YFP-based PCA approach can specifically 
detect interactions between components of the HMS and its protein interaction partners. 
To assess the reliability of our bioreactor-TAP-MS/MS results, a sample set of seven proteins 
occupying key functions or central positions in the general interaction network, namely EF-2 
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(Q60875), ATP-dependent RNA helicase, PAI-RBP1 (Q9CY58), TDP-43 (Q921F2), LDH-A 
(P06151), DNA replication licensing factor MCM5 (P49718) and NPM (Q61937), as well as 
DDX3X (Q62167) as a member of the ‘bead proteome’ filter, were tested in experiments aimed 
at validating these proteins’ network connections by reciprocal TAP and in viable cells using the 
PCA (Fig.4D-G). eIF-5A1 displayed significant close-range interactions with EF-2, PAI-RBP1, 
TDP-43, LDH-A and NPM (Fig. 4D). Interactions with PAI-RBP1, TDP-43 and NPM could also 
be confirmed for eIF-5A2. However, the putative interaction between EF-2 and eIF-5A2 was less 
pronounced and did not reach statistical significance (Fig. 4E). DHS and DOHH both showed 
significant interaction with LDH-A, and DOHH also interacted with pyruvate kinase isozymes 
M1/M2 (P52480), which was uniquely identified in one of the DOHH (SG) technical replicates 
(Fig. 4F and G). For eIF-5A1, 5 of 7 tested proteins could be confirmed, all of which were 
identified in bioreactor-TAP-MS/MS using eIF-5A1 as bait. The remaining two proteins (MCM5 
and DDX3X) were identified in all HMS sets and likely represent proteins that belong into the 
bead proteome category. In fact, DDX3X was also identified in MS/MS samples from eGFP (SG) 
TAP experiments and thus removed from the adjusted dataset upon application of the bead 
proteome filter. For the PCA combinations involving the other HMS proteins, not all of the tested 
proteins were also found in the respective bioreactor-TAP-MS/MS sets. Since most tested 
proteins that were also identified as interaction partners in the bioreactor-TAP-MS/MS did 
interact with the respective baits, these findings confirm the general validity of our TAP-MS/MS 
data. 
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The eIF-5A protein displays hypusine-independent interactions with ribosomal proteins 
Rpl10a and Rps5 
Consistent with eIF-5A’s proposed function in translation, we identified numerous ribosomal 
proteins in our purification protocol. A recent report described the crystal structure of the 
prokaryotic ortholog of eIF-5A, EF-P, bound to the prokaryotic 70S ribosome. This study 
revealed that EF-P’s interaction with the 70S ribosome occurs directly adjacent to the ribosomal 
proteins Rps7p and Rpl1p (54). As both eukaryotic orthologs of these proteins, 40S ribosomal 
protein S5 (Rps5, P97461) and 60S ribosomal protein L10a (Rpl10a, P53026), also appeared in 
the TAP-MS/MS results (Table S1), we chose to analyze their interactions with eIF-5A in greater 
detail. As expected, both eIF-5A isoforms showed significant interaction with both ribosomal 
proteins in the PCA (Fig. 5B, D, F, and H). Fluorescence microscopy images showed the 
characteristic pattern of ribosomal proteins, with high signal intensity in nucleoli and a lower 
diffuse fluorescence emitted from the cytoplasm and nucleus (Fig. 5A, C, E, and G). Since non-
hypusinated eIF-5A is inactive in protein translation and/or initiation (55, 56), we expected the 
interaction to involve the N-terminal region of eIF-5A, as it harbors the Lys50 residue that is 
eventually modified to hypusine. While both eIF-5A1-83 isoforms showed a trend of elevated 
fluorescence intensity, only eIF-5A11-83/Rps5 and eIF-5A21-83/Rpl10a reach statistical 
significance (Fig. 5F and D, respectively). However, none of the four combinations involving 
eIF-5A84-154 showed significant interactions, highlighting the N-terminus as the primary site for 
ribosomal interaction of eIF-5A. Interestingly, the association of eIF-5A with these proteins 
could not be significantly reduced by the introduction of point mutants that render eIF-5A 
hypusine-deficient, indicating that the interaction of eIF-5A1 and eIF-5A2 with these components 
of the ribosomal complex occurs in a hypusine-independent fashion. Reciprocal TAP 
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experiments using Rps5 and Rpl10a as bait proteins, followed by Western blot detection of eIF-
5A1, showed a positive signal only in case of Rps5, but not with Rpl10a (Fig. 5I). 
NPM and TDP-43 also show interactions with eIF-5A 
Our interaction network revealed the previously unknown interaction of eIF-5A with NPM and 
TDP-43, two proteins that presumably have no general role in mRNA translation. We further 
analyzed these particular proteins in order to gain more insight into potential eIF-5A functions 
outside of translation (Fig. 6). Notably, TDP-43 displayed the strongest interactions with eIF-5A 
both in PCA and Western blot analysis of reciprocal TAP experiments (Fig. 4D and E, Fig. 6B, D 
and I). TDP-43 is a DNA- and RNA-binding protein that has previously been implicated in the 
regulation of transcription and splicing, and is linked to neurodegenerative disease (reviewed in 
(57)). By analyzing eIF-5A mutants, we found that an interaction of eIF-5A1 to TDP-43 was 
detectable using the N-terminal domain of eIF-5A1, but not its C-terminal domain (Fig. 6B). As 
the eIF-5A11-83/TDP-43 signal reaches only about 40% of the wild type combination, the C-
terminal domain seems to also be involved in some aspect of the interaction, without specifically 
binding to TDP-43 itself. Additionally, both the eIF-5A1K50R and the eIF-5A1G52A mutants 
showed significantly diminished interaction with TDP-43 compared to the wild type form, 
consistent with a significant dependency on hypusine formation for this interaction (Fig. 6B). For 
the different forms of eIF-5A2, the PCA showed less pronounced differences in TDP-43 
interaction (Fig. 6D). Thus, our data validate NPM and TDP-43 as additional direct or indirect 
binding partners of eIF-5A that, in case of TDP-43, interact in a hypusine-dependent fashion. 
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The eIF-5A and DHS proteins show partial co-localization to cytoplasmic multivesicular 
bodies (MVBs) in PCA experiments 
As shown in Fig. 4C, we reproducibly observed very low diffuse cytoplasmic fluorescence and 
speckles of high YFP signal intensities in PCA experiments conducted to determine the 
interaction of both isoforms of eIF-5A with DHS (Fig. 7A). We were unable to elicit a similar 
effect with any other binding partner of eIF-5A or DHS. Furthermore, the overexpression of 
eGFP-tagged fusion proteins of either eIF-5A or DHS alone resulted in the expected, diffuse 
cytoplasmatic fluorescence signal, and no speckles of high fluorescence activity were observed 
(Fig S6). To exclude the possibility that these speckles represent unspecific protein aggregation, 
experiments were conducted with various eIF-5A mutants and DHS in combination with GC7 
(N1-guanyl-1,7-diaminoheptane), a small molecular weight DHS-inhibitor that impedes hypusine 
formation (58). In contrast to the mutant forms eIF-5AG52A and eIF-5A84-154, wild type eIF-5A1, 
eIF-5A11-83 and eIF-5A1K50R evoked the formation of YFP spot-like signals. Moreover, inhibition 
of DHS by 20 µM of GC7 appeared to inhibit this specific cytoplasmic localization, strongly 
suggesting that DHS enzymatic activity is required for this localization pattern (Fig. 7A). We 
then tested whether these fluorescent speckles occurred due to the localization of eIF-5A/DHS to 
specific cytoplasmic organelles. Some organelles or organelle-related mechanisms have been 
previously reported to be associated with eIF-5A activity, including the endoplasmatic reticulum 
(ER) (59), autophagosomes (60), processing bodies (PB) (55) and stress granules (SG) (61). We 
therefore performed various co-localization studies, analyzing the aforementioned compartments 
as well as endosomal sorting complex required for transport I (ESCRT-I) complex subunit 
TSG101 (TSG101). This protein is located at late endosomal multivesicular bodies (MVB), 
primarily orchestrating intracellular protein sorting and trafficking (62). For this we generated 
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various fluorescent fusion marker proteins and cotransfected these respective expression vectors 
together with our eIF-5A/DHS PCA constructs. In addition, the desired localization patterns of 
autophagosome marker protein autophagy-related protein LC3 (LC3) and SG-marker TIA-1 were 
induced by chloroquine or puromycin treatment, respectively. The fluorescence microscopy 
analyses revealed that the majority of these marker proteins did not significantly co-localize with 
eIF-5A/DHS (Fig. S7A). In contrast, signals that appeared in the respective channel of mRFP-
TSG101 or Cer2-TSG101 cotransfected cells partially overlapped with the eIF-5A/DHS speckles 
in the YFP channel (Fig. 7B). We then performed fluorescence-based immunolabeling of a 
second endosomal marker, early endosome antigen 1 (EEA1), a protein located primarily in the 
membranes of early endosomes with a role in endosomal trafficking. As shown in Figure 7C, 
speckles of eIF-5A1/DHS PCA cotransfected cells co-localized with EEA1. On the other hand, 
the ER-marker calreticulin did not show a similar significant co-localization to eIF-5A/DHS 
within the same experimental setting (Fig. S7B). These observations suggest that the eIF-
5A/DHS interaction may take place either in association with or in close proximity to 
components of the endosomal pathway. 
Discussion 
Hypusine is a unique post-translational modification that mediates important cellular functions 
and has been demonstrated to be involved in the pathogenesis and development of cancer and 
other highly prevalent diseases like diabetes and AIDS (reviewed in (63-65)). As such, it 
potentially represents a unique target for the development of novel therapeutic approaches in 
these conditions (reviewed in (66)). To elucidate the role of the unique hypusine-containing eIF-
5A protein in cell biology and pathology in more detail, we have combined a TAP-MS/MS 
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approach with the production of high amounts of cellular input material in a bioreactor, ensuring 
reproducible culture conditions, and applied it to all four proteins of the HMS. 
In the resulting dataset, factors related to protein synthesis represent the biggest subgroup of the 
231 identified proteins co-purified with both eIF-5A isoforms (52.4% and 70.2% for eIF-5A1 and 
eIF-5A2, respectively), as defined by GO categories. As expected, the most significant cluster 
that we identified in our hypusine network was exclusively composed of proteins related to 
ribosomal function. However, we were also able to identify a large number of additional proteins 
that have been reported to elicit completely different function and might help to shed light on the 
mechanisms that underlie the various eIF-5A activities. The previously proposed roles of eIF-5A 
in specific transport of mRNA, mRNA maturation, and mRNA stability in mammals (24, 67-69), 
coincide with the finding that a majority of the identified proteins (69.0% and 72.7%) in the eIF-
5A datasets are classified as RNA-binding. This finding is further supported by cluster analysis, 
which revealed two clusters in our network that are mostly comprised of RNA-binding proteins 
active in RNA transport, processing and translation. The final overrepresented subgroup of 
proteins in GO and cluster analysis has regulatory functions in the cell cycle. This finding is 
particularly intriguing, since it suggests that the effects of eIF-5A on control of cellular 
proliferation may involve direct communication with the cell cycle control machinery, rather than 
simply being a downstream consequence of effects on gene expression, and might help to further 
explain observed cellular growth phenotypes after HMS inhibition. Indeed, this finding is 
consistent with recent studies that report eIF-5A to be crucially involved in normal and aberrant 
proliferation control (70, 71). 
The comparison of available data from high-throughput studies in yeast (available via the IntAct 
database) and the dataset presented in this study shows remarkable differences, as all common 
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orthologs of proteins binding to eIF-5A are related to protein translation and none of the 
identifiable yeast orthologs of the proteins with different functional relationships were also found 
in yeast-based studies. A possible hypothesis that provides an explanation for these observations 
is that, while the translational regulatory function mediated by ribosome interaction may be the 
original function of eIF-5A and is highly conserved in evolution, additional roles for eIF-5A in 
the biology of more complex multicellular organisms might have developed over time. The 
fulfillment of this broader spectrum of cell biological functions would then require a 
commensurate extension of the set of interaction partners. In support of this hypothesis, 
phenotypes of mutations in yeast and D. melanogaster DOHH orthologs (LIA1 and nero, 
respectively) show remarkable differences: while LIA1-activity depleted yeast cells elicit only a 
mild reduction of their growth rate (17), Drosophila develops negative and eventually fatal 
effects on organism viability, organ development and processes like cell growth, proliferation and 
autophagy (72). 
The idea of diverged eIF-5A functions in multicellular organisms may also extend to the protein 
isoforms themselves. As our data also identify significant differences in PPI for both isoforms, it 
seems reasonable to hypothesize that, beyond shared ancestral and ‘add-on’ functions, eIF-5A1 
executes a universal set of functions in cells of most or all tissues, while eIF-5A2 has developed 
other, more tissue-specific functions, for example in embryonic development or the nervous 
system. It is possible that this specialization also entails isoform-specific roles of eIF-5A in 
dedifferentiation and mobilization of cancer cells. In possible support of this notion, up-
regulation of eIF-5A2 − but not eIF-5A1 − expression has been detected in hepatocellular 
carcinoma and could be connected to metastasis thereof , and is a prognostic marker for clinical 
outcome of lung cancer patients (22). Of note, eIF-5A2 has also been implicated in development 
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of ovarian cancer and therefore been considered as an oncogene (21). Intriguingly, we have 
identified cytoskeleton-associated protein 5, which is over-expressed in hepatomas and colonic 
tumors (73), as a selective interaction partner specifically of eIF-5A2 (Fig 2A, Table S1). The 
expression in testis and CNS, as well as a study screening for mutations of the gene encoding 
human eIF-5A2 (EIF5A2) in infertile men (74), also suggest a special role of eIF-5A2 in 
spermatogenesis and neuronal function. Other newly identified interactions with eIF-5A2 (but not 
eIF-5A1) are also compatible with this supposition: GSK-3β (Q9WV60), which is highly 
expressed in testis and involved in cell migration regulation (75), GCD (Q60759), which is 
connected to glutaric aciduria type 1 (76), and UGT1 (Q6P5E4), which is highly expressed in 
brain tissue, all interact selectively with eIF-5A2. TDP-43, which is connected to amyotrophic 
lateral sclerosis type 10 (77), has been identified in the eIF-5A2 dataset by bioreactor-TAP-
MS/MS and was found to interact with both isoforms of eIF-5A during experimental validation. 
It is important to note that the identification of PPI that mediate cellular functions specific to 
certain tissues might be impossible in cells derived from other tissues. Thus, a screening for eIF-
5A2 binding partners in a neuronal or male germ cell context would presumably result in a 
different, arguably larger set of putative interaction partners. However, it is noteworthy that half 
of the eIF-5A2-specific subset found in our screening in pro-B lymphocytes is composed of 
proteins that are reported to be highly expressed and to have specific functions in brain and testis 
biology and pathophysiology. 
To our knowledge, this is the first time that DHS and DOHH have been selectively screened for 
unknown PPI partners. However, in contrast to eIF-5A, our data do not suggest a similar 
functional diversity for the enzymes DHS and DOHH. Compared to eIF-5A, we have identified 
only few putative interaction partners for DHS and DOHH, and both datasets share a significant 
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overlap with the eIF-5A isoforms, suggesting direct interactions only with one of the respective 
bait proteins. Furthermore, we could not find significant sequence homology to the highly 
conserved hypusination site of eIF-5A in any of the proteins co-purified with DHS and DOHH, 
suggesting that the mode of interaction in these cases would have to be different from that of eIF-
5A. Taken together, this supports the hypothesis that the function of both of these enzymes is 
focused on the hypusine modification of eIF-5A. However, as both sets contain proteins that are 
active regulators of different phases in cell proliferation, including E3 ubiquitin-protein ligase 
TRIM33 (Q99PP7), CEP55 (Q8BT07), kinesin-like proteins KIF2A and KIF2C as well as DNA 
replication licensing factors MCM3 (P25206) and MCM5, it is intriguing to speculate that DHS 
and DOHH activity, and thereby eIF-5A activation, might also be regulated in this context. 
As discussed above, many of the proteins identified in this study provide important hints about 
postulated and potential unknown molecular and cellular functions of eIF-5A and the hypusine 
modification. Using hypusine-deficient and deletion mutants of eIF-5A in PCA and TAP 
experiments, we have determined the impact of hypusine on newly identified eIF-5A interactions. 
Of course, the absence of changes in PPI in hypusine-deficient eIF-5A does not necessarily imply 
that the respective function is unaffected. For instance, eIF-5AK50R shows specific interaction 
with DHS in PCA, even though eIF-5AK50R cannot be hypusinated and thus the interaction 
remains non-effective in functional terms. 
In case of Rpl10a and Rps5, both eIF-5AK50R and eIF-5AG52A mutants did not show a reduction in 
signal intensity in the interaction with either Rps5 or Rpl10a. This is in contrast to data collected 
in yeast (78), which showed a remarkable decrease of co-purified ribosomal proteins with 
hypusine deficient mutant compared to wild type eIF-5A. A possible interpretation for this 
difference is that the interaction of hypusine deficient mutant eIF-5A with the ribosome is not 
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completely abolished, but has an increased dissociation constant that results in significant loss of 
co-purification capacity. In our live-cell PCA, however, the strong association of split-YFP 
fragments after initial complementation might mask this effect of eIF-5A mutation. The binding 
of mutated eIF-5A might also be explained by the presence of endogenous eIF-5A and the 
occurrence of wild type/mutant eIF-5A dimerization with the wild type form bound to the 
ribosome. Another possibility is that we observe indirect interactions with the ribosome via 
actively translated mRNAs that bind eIF-5A in a hypusine-independent manner. This interaction 
might be lost over time during the purification process but would be detectable in PCA. 
Nevertheless, the N-terminal deletion mutant showed a significant reduction of ribosomal 
interaction and the C-terminal, non-hypusinated domain showed no interaction with the analyzed 
ribosomal proteins, indicating that the interaction interface is in fact contained in the hypusine-
containing domain of the protein. Moreover, the reciprocal TAP assay resulted in a difference of 
co-purified eIF-5A1 with Rps5 and Rpl10a. While co-purification was detectable with Rps5, no 
eIF-5A1 signal was detectable using Rpl10a as bait. While this observation might be effected by 
geometrically inhibiting the interaction due to the introduction of the sizeable TAP tag, it likely 
suggests a more robust association of eIF-5A to the 40S subunit of the ribosome. 
One of the many RNA-binding proteins in the eIF-5A dataset is TDP-43, which exhibited the 
strongest eIF-5A interaction of all candidates included in our validation experiments. 
Interestingly, it has also been reported to be a primarily nuclear RNA-binding protein that 
regulates pre-mRNA splicing (57, 79). At this point we do not know if eIF-5A’s interaction with 
TDP-43 is direct or mediated by RNA or other binding partners. However, the relative strength of 
the interaction as compared to all other tested proteins together with our ability to detect it 
consistently in both our in vivo and in vitro interaction assays suggests it is more likely to be 
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direct. An additional link to eIF-5A exists through the negative regulation of HIV-1 transcription 
(80), since eIF-5A1 is also a regulator of HIV-1 replication (25). 
Taken together, the results of these validation assays confirmed the specificity of co-purification 
in the bioreactor-TAP-MS/MS assay with eIF-5A and indicate that, while the interaction of these 
proteins selected for validation with eIF-5A is domain-specific, it does not seem to generally rely 
on the integrity of the hypusine modification. This finding is in conflict with several reports that 
showed an essential role of hypusination in eIF-5A function. We envisage three possible 
interpretations for these hypusine-independent interactions: 1) they are not important for eIF-5A 
function; 2) they are important for a hypusine-dependent eIF-5A function, even though they are 
not themselves hypusine-dependent; 3) the interactions are important for a hypothetical hypusine-
independent function of eIF-5A. Differentiating between these scenarios will require further 
experiments to test the importance of these interactions in functional assays. 
Finally, the finding that eIF-5A1 and DHS co-localize with components of the endosomal sorting 
complex machinery may indicate that hypusination of eIF-5A influences the intracellular 
trafficking and, thus, the localization of eIF-5A. Alternatively, its co-localization with ESCRT-I 
components may reflect a function that is unrelated to vesicular transport. Of note, evidence has 
been provided that particularly TSG101 plays a role in cell cycle control (see (81) and references 
therein). Similar activities have also been described for hypusine-modified eIF-5A (6, 10, 11). 
This might indicate that both, eIF-5A and TSG101 (or related factors), are components of the 
same pathway regulating the proliferation and survival of tumor cells. 
In summary, we have presented the bioreactor-TAP-MS/MS procedure, making use of highly 
sensitive mass spectrometers and linking of the assay to high-quality cell production in a 
bioreactor, and produced evidence for its high reliability. Application to the HMS proteins 
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generated new evidence for these proteins’ various functions. Moreover, our results are 
compatible with the idea of new ‘add-on’ functions of eIF-5A acquired during its evolutionary 
development, some of which may be isoform-specific and especially important for multicellular 
organisms. As with any screening approach, our results have generated a far greater number of 
hypotheses about hypusine dependent molecular and cellular functions than could possibly be 
addressed in the present study; these will be the subject of future studies. Indeed, for this very 
reason, we are confident that the ongoing search for molecular mechanisms that can 
comprehensively explain eIF-5A functions will benefit significantly from this rich resource. 
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Figure legends 
Fig. 1. The hypusine modification and TAP fusion proteins employed in this study. (A) The 
hypusine modification pathway and major proposed eIF-5A functions. (B) Structure of the 
plasmid inserts coding for SG-tagged bait proteins. The amino acid positions of eIF-5A mutants 
are indicated in italic. SBP = streptavidin binding peptide. (C) Metabolic incorporation of 
3
H-
labelled spermidine into eIF-5A. Arrowheads indicate bands of SG-tagged and endogenous eIF-
5A proteins. (D) Anti-Myc-tag Western blot of cell lysates from retrovirally transduced Ba/F3 
p210 cell lines for the quantification of constitutively expressed SG-tagged bait proteins. (E) 
Representative TAP outputs for MS/MS analysis, after 1D PAGE separation and Coomassie 
staining. Separation distance varies from approximately 2 to 4 cm. 
 
Fig. 2. A comprehensive protein-protein interaction network of the hypusine modification 
system. (A) A spoke network of the four sets of identified proteins (own data, solid edges) was 
interconnected by querying the STRING and IntAct databases with all identified proteins for 
experimentally determined interactions and those listed in manually curated databases 
(previously existing external data, dashed edges). Main localizations (node shape) and functions 
(node color) of proteins were queried from Ingenuity Pathway Analysis. See legend for 
clarification of node and edge color and shape code. Proteins represented by red-bordered nodes 
were not identified in this study but have been reported as putative interaction partners by other 
studies. (B) Comparison of the numbers of proteins identified in this study and those obtained 
from online databases. Values in parentheses include proteins that were removed with the ‘bead 
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proteome’ filter. Note that our method has identified 239 new proteins as putative interaction 
partners of HMS members. 
 
Fig. 3. Identification of protein-protein interaction (PPI) clusters and evolutionary 
conservation of the hypusine network. (A to E) The network shown in Figure 2A was analyzed 
for significant PPI clusters via the ClusterONE Cytoscape plug-in. All clusters with P < 0.05 
were extracted from the network and analyzed for common key protein functions. See legend for 
clarification of node and edge color and shape code. 
 
Fig. 4. Establishment of a protein fragment complementation assay (PCA) assay to validate 
newly identified PPI. (A) Mechanism of the split-YFP PCA assay: upon interaction of proteins 
A and C, the YFP fragments can fold into YFP’s native state, leading to fluorescence activity (B) 
Flow cytometric evaluation of previously known PPI and negative controls involving eIF-5A1- 
and MCFD2-YFP1. Corresponding YFP2-coupled protein is indicated by shape. MCFD2-YFP1 
and ERGIC-53-YFP2 are known to interact (31) and show MCFD2-YFP1 is expressed and 
functional, confirming it’s applicability as negative control. Values represent mean fluorescence 
of viable cotransfected cells. (C) Representative microscopic pictures of a control combination 
(eIF-5A2 + MCFD2) and a known interaction (eIF-5A2 + DOHH). The elevated background of 
the control originates from prolonged exposure. (D to G) Flow cytometric quantification of PCA 
experiments with combinations of known and newly identified putative interaction partners. Bars 
represent mean fluorescence of two independent runs of duplicates (n = 4) normalized to negative 
control experiments (grey dashed lines). Error bars represent standard error of the mean (SEM). 
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Asterisks (*) represent statistically significant variation from the respective negative control (* 
P < 0.05; ** P < 0.01; *** P < 0.001). 
 
Fig. 5. Validation and further evaluation of putative eIF-5A interactions with RPS5 and 
RPL10a. (A, C, E, and G) Fluorescence microscopy images of representative YFP-positive cells 
of PCA experiments as indicated on panels. (B, D, F, and H) Flow cytometric quantification of 
PCA experiments as indicated on panels. Bars represent mean fluorescent values of two 
independent runs of duplicates (n = 4) normalized to negative control experiments (dashed lines). 
Error bars represent SEM. Asterisks (*) represent statistically significant variation from the 
respective control or the wild type combination (* P < 0.05; ** P < 0.01; *** P < 0.001). (I) 
Western blots of TAP outputs from reciprocal pull-down experiments employing newly identified 
putative eIF-5A interaction partners as bait proteins and eGFP (SG) as negative control. Anti-
Myc-tag detects bait proteins via the TAP-tag. All outputs were processed on the same 
gel/membrane, all shown bands originate from the same exposure. 
 
Fig. 6. Validation and further evaluation of putative eIF-5A interactions with TDP-43 and 
NPM. (A, C, E, and G) Fluorescence microscopy images of representative YFP-positive cells of 
PCA experiments as indicated on panels. (B, D, F, and H) Flow cytometric quantification of 
PCA experiments as indicated on panels. Bars represent mean fluorescent values of two 
independent runs of duplicates (n = 4) normalized to negative control experiments (dashed lines). 
Error bars represent SEM. Asterisks (*) represent statistically significant variation from the 
respective control or the wild type combination (* P < 0.05; ** P < 0.01; *** P < 0.001). (I) 
Western blots of TAP outputs from reciprocal pull-down experiments employing newly identified 
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putative eIF-5A interaction partners as bait proteins. Anti-Myc-tag detects bait proteins via the 
TAP-tag. All outputs were processed on the same gel/membrane, all shown bands originate from 
the same exposure. 
 
Fig. 7. Specificity and subcellular localization of observed eIF-5A1/DHS-complexes. 
Fluorescence microscopy images showing representative YFP-positive cells from PCA 
experiments as indicated on the panels. Green channel = reconstituted YFP; red channel = mRFP 
or Alexa633 (immunolabeling experiments); blue channel = Cer2. (A) Wild type eIF-5A1, the 
eIF-5A1K50R mutant and the N-terminal domain of eIF-5A1 show YFP speckles upon binding of 
DHS in PCA experiments. The eIF-5A1G52A mutant, the C-terminal domain of eIF-5A1 and 
addition of 20 µM GC7 disrupt this localization of eIF-5A1/DHS PCA complexes. (B) A fusion 
protein from fluorescent proteins mRFP or Cer2, respectively, and TSG101 (member of the 
ESCRT-I protein family and marker for MVBs) showed significant co-localization with eIF-
5A1/DHS PCA complexes. Most double-positive cells showed more speckles of eIF-5A1/DHS 
PCA complex localization than MVBs, but the majority of labeled MVBs co-localized to eIF-
5A1/DHS PCA complexes. (C) Immunolabeled EEA1 (marker for early endosomes) also showed 
significant co-localization with eIF-5A1/DHS PCA complexes.  
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Figure 2A-B 
 
 
Figure 3A-E 
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Figure 4A-G 
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Figure 5A-I 
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Figure 6A-I 
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Figure 7A-C 
